Fecal marker levels as predictors of need for endoscopic balloon dilation in Crohn’s disease patients with anastomotic strictures

Figure 1 Study flowchart. CD: Crohn’s disease.

Figure 2 Box plots of fecal markers according to endoscopic activity defined by the modified Rutgeerts score, in asymptomatic patients presenting with anastomotic strictures. A: Fecal calprotectin; B: Fecal lactoferrin.

Figure 3 Receiver operating characteristic curves for fecal markers for discriminating between endoscopic recurrence and remission in asymptomatic patients presenting with anastomotic strictures. A: Fecal calprotectin; B: Fecal lactoferrin.